Medicine
Showing 1,451-1,500 of 2,393 Results
-
Andrew Napier
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioAndrew Napier, MD, FAAEM, is a board-certified emergency physician, Army veteran, and founder of two clinical tech companies. He built and FDA-cleared a single-use video laryngoscope with on-blade lens clearing and leads development of real-time procedural guidance for intubation and bronchoscopy. He also co-founded an ambient documentation platform now producing hundreds of thousands of structured charts across 100+ care sites. His work focuses on clinician adoption, safety, and measurable impact at the bedside—pairing device design with on-device AI, rigorous validation, and clear change management.
At Stanford (MCiM), his interests include human-in-the-loop guidance for high-risk procedures, ambient clinical assistants that lower cognitive load, and pragmatic trials that track speed, accuracy, and downstream outcomes. Previously Vice Chair/Assistant Medical Director at a 70k-visit ED, he led sepsis, documentation, and operations projects; he holds issued and pending patents, published on lens-clearing laryngoscopy (AJEM), and has led cross-functional teams through FDA compliance and commercial launch. He served as a combat medic in Afghanistan and later as an EM physician at high-acuity trauma centers. -
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Michael Nedelman
Adjunct Lecturer, Medicine - Primary Care and Population Health
BioDr. Michael Nedelman leads the Stanford Health Equity Media Fellowship. He previously covered health and medicine as a journalist for CNN, earning an Emmy nomination for the network's acclaimed reporting on the Covid-19 pandemic. As producer for the inimitable Dr. Sanjay Gupta, he was part of a team known for excellent reporting and storytelling — also winning a Cronkite Award for tackling misinformation during the pandemic. Before CNN, he was a digital producer for the ABC News Medical Unit, worked on public health campaigns at the World Health Organization in New Delhi, and trained at the Stanford Journalism Program as part of the university's Global Health Media Fellowship. He received his MD from Stanford and did his undergraduate work in film at Yale.
-
Margaret Jane Neff
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Medical Director--Vapahcs Medical Surgical Icu, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioMy training is in Pulmonary & Critical Care Medicine, and I've been blessed to be part of the care of many patients and their families. My clinical research interests have been in the field of critical care medicine and ARDS, a type of acute respiratory failure seen commonly in patients with severe injuries or illnesses. I also have a particular interest in evaluating and improving processes for care. Issues like standardizing processes to improve reliability, improving safety of handoffs, and exploring ways to teach "roundsmanship" (the process of discussing patients' care with a group of providers) are current interests of mine.
The future of medical care depends on training the next generation of providers, and I'm thankful to be part of training this next generation. Teaching at the bedside or in formal classroom settings gives me great joy and satisfaction. I'm delighted to work with a great, multidisciplinary team of physicians, nurse practitioners, nurses, respiratory therapists, and pharmacists. I add to that team our patients and families, for it truly takes a team to provide care that is both excellent and compassionate. -
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Carter Neugarten
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Neugarten is a recognized healthcare leader and national expert at the crossroads of palliative care and emergency medicine. He has published widely in this field, and his initiatives focus on enhancing upstream palliative care accessibility, resource optimization in healthcare, and harnessing telemedicine's potential in providing care.
His contributions include co-chairing a national committee that fosters innovation by merging these fields, and he has received grant funding to study the impact of palliative care referral from the ED.
Dr. Neugarten also has an established footprint in medical education, having held multiple formal teaching roles throughout his career. -
Andrew Nevins
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Minh Nguyen
Contingent Employee, Medicine - Med/Cardiovascular Medicine
BioPrevious bio as a PhD student:
@DARE fellow (Diversifying Academia, Recruiting Excellence) https://vpge.stanford.edu/people/minh-nguyen
@Data Science Scholar https://datascience.stanford.edu/people/minh-nguyen -
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders.
